400 related articles for article (PubMed ID: 31447834)
1. The Endless Saga of Monocyte Diversity.
Canè S; Ugel S; Trovato R; Marigo I; De Sanctis F; Sartoris S; Bronte V
Front Immunol; 2019; 10():1786. PubMed ID: 31447834
[TBL] [Abstract][Full Text] [Related]
2. Monocytes in the Tumor Microenvironment.
Ugel S; Canè S; De Sanctis F; Bronte V
Annu Rev Pathol; 2021 Jan; 16():93-122. PubMed ID: 33497262
[TBL] [Abstract][Full Text] [Related]
3. The continuum of monocyte phenotypes: Experimental evidence and prognostic utility in assessing cardiovascular risk.
Cignarella A; Tedesco S; Cappellari R; Fadini GP
J Leukoc Biol; 2018 Mar; ():. PubMed ID: 29603382
[TBL] [Abstract][Full Text] [Related]
4. The Ontogeny of Monocyte Subsets.
Wolf AA; Yáñez A; Barman PK; Goodridge HS
Front Immunol; 2019; 10():1642. PubMed ID: 31379841
[TBL] [Abstract][Full Text] [Related]
5. The CD14
Mengos AE; Gastineau DA; Gustafson MP
Front Immunol; 2019; 10():1147. PubMed ID: 31191529
[TBL] [Abstract][Full Text] [Related]
6. Plasticity of monocyte development and monocyte fates.
Trzebanski S; Jung S
Immunol Lett; 2020 Nov; 227():66-78. PubMed ID: 32814154
[TBL] [Abstract][Full Text] [Related]
7. Monocyte programming by cancer therapy.
Patysheva M; Frolova A; Larionova I; Afanas'ev S; Tarasova A; Cherdyntseva N; Kzhyshkowska J
Front Immunol; 2022; 13():994319. PubMed ID: 36341366
[TBL] [Abstract][Full Text] [Related]
8. Recruited monocytic myeloid-derived suppressor cells promote the arrest of tumor cells in the premetastatic niche through an IL-1β-mediated increase in E-selectin expression.
Shi H; Zhang J; Han X; Li H; Xie M; Sun Y; Liu W; Ba X; Zeng X
Int J Cancer; 2017 Mar; 140(6):1370-1383. PubMed ID: 27885671
[TBL] [Abstract][Full Text] [Related]
9. Current State of Dendritic Cell-Based Immunotherapy: Opportunities for
Huber A; Dammeijer F; Aerts JGJV; Vroman H
Front Immunol; 2018; 9():2804. PubMed ID: 30559743
[TBL] [Abstract][Full Text] [Related]
10. Increased numbers of monocyte-derived dendritic cells during successful tumor immunotherapy with immune-activating agents.
Kuhn S; Hyde EJ; Yang J; Rich FJ; Harper JL; Kirman JR; Ronchese F
J Immunol; 2013 Aug; 191(4):1984-92. PubMed ID: 23858033
[TBL] [Abstract][Full Text] [Related]
11. A Novel, Five-Marker Alternative to CD16-CD14 Gating to Identify the Three Human Monocyte Subsets.
Ong SM; Teng K; Newell E; Chen H; Chen J; Loy T; Yeo TW; Fink K; Wong SC
Front Immunol; 2019; 10():1761. PubMed ID: 31402918
[TBL] [Abstract][Full Text] [Related]
12. Monocytes and dendritic cells in a hypoxic environment: Spotlights on chemotaxis and migration.
Bosco MC; Puppo M; Blengio F; Fraone T; Cappello P; Giovarelli M; Varesio L
Immunobiology; 2008; 213(9-10):733-49. PubMed ID: 18926289
[TBL] [Abstract][Full Text] [Related]
13. Differentiation and function of mouse monocyte-derived dendritic cells in steady state and inflammation.
Domínguez PM; Ardavín C
Immunol Rev; 2010 Mar; 234(1):90-104. PubMed ID: 20193014
[TBL] [Abstract][Full Text] [Related]
14. Targeting monocyte-intrinsic enhancer reprogramming improves immunotherapy efficacy in hepatocellular carcinoma.
Liu M; Zhou J; Liu X; Feng Y; Yang W; Wu F; Cheung OK; Sun H; Zeng X; Tang W; Mok MTS; Wong J; Yeung PC; Lai PBS; Chen Z; Jin H; Chen J; Chan SL; Chan AWH; To KF; Sung JJY; Chen M; Cheng AS
Gut; 2020 Feb; 69(2):365-379. PubMed ID: 31076403
[TBL] [Abstract][Full Text] [Related]
15. Monocyte Subsets: Phenotypes and Function in Tuberculosis Infection.
Sampath P; Moideen K; Ranganathan UD; Bethunaickan R
Front Immunol; 2018; 9():1726. PubMed ID: 30105020
[TBL] [Abstract][Full Text] [Related]
16. Monocyte heterogeneity and functions in cancer.
Olingy CE; Dinh HQ; Hedrick CC
J Leukoc Biol; 2019 Aug; 106(2):309-322. PubMed ID: 30776148
[TBL] [Abstract][Full Text] [Related]
17. Monocytes in Tumorigenesis and Tumor Immunotherapy.
Chen X; Li Y; Xia H; Chen YH
Cells; 2023 Jun; 12(13):. PubMed ID: 37443711
[TBL] [Abstract][Full Text] [Related]
18. Plasticity of myeloid-derived suppressor cells in cancer.
Tcyganov E; Mastio J; Chen E; Gabrilovich DI
Curr Opin Immunol; 2018 Apr; 51():76-82. PubMed ID: 29547768
[TBL] [Abstract][Full Text] [Related]
19. Delivery of TLR7 agonist to monocytes and dendritic cells by DCIR targeted liposomes induces robust production of anti-cancer cytokines.
Klauber TCB; Laursen JM; Zucker D; Brix S; Jensen SS; Andresen TL
Acta Biomater; 2017 Apr; 53():367-377. PubMed ID: 28153581
[TBL] [Abstract][Full Text] [Related]
20. Functional crosstalk between T cells and monocytes in cancer and atherosclerosis.
Padgett LE; Araujo DJ; Hedrick CC; Olingy CE
J Leukoc Biol; 2020 Jul; 108(1):297-308. PubMed ID: 32531833
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
